Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (21)
Ga Eun Kim, Mi Reu Park, Jae Hwa Jung, Soo Yeon Kim, Min Jung Kim, Yoon Hee Kim, Kyung Won Kim & Myung Hyun Sohn. (2022) Usefulness of extended nitric oxide analysis in children with allergic rhinitis. Journal of Asthma 59:4, pages 739-745.
Read now
Read now
Narongwit Nakwan & Tanaporn Prateepchaiboon. (2022) Predicting the requiring intubation and invasive mechanical ventilation among asthmatic exacerbation-related hospitalizations. Journal of Asthma 59:3, pages 507-513.
Read now
Read now
Trung N Tran, Marjan Kerkhof, Victoria Carter & David B Price. (2021) Persistence of Eosinophilic Asthma Endotype and Clinical Outcomes: A Real-World Observational Study. Journal of Asthma and Allergy 14, pages 727-742.
Read now
Read now
Daniel C. Gibbons, Bhumika Aggarwal, Jolyon Fairburn-Beech, David Hinds, Monica Fletcher, Sinthia Bosnic-Anticevich & David Price. (2021) Treatment patterns among non-active users of maintenance asthma medication in the United Kingdom: a retrospective cohort study in the Clinical Practice Research Datalink. Journal of Asthma 58:6, pages 793-804.
Read now
Read now
Garry M. Walsh. (2020) Anti-IL-5 monoclonal antibodies for the treatment of asthma: an update. Expert Opinion on Biological Therapy 20:10, pages 1237-1244.
Read now
Read now
A. Viinanen, M. I. Lassenius, I. Toppila, A. Karlsson, L. Veijalainen, J. J. Idänpään-Heikkilä & T. Laitinen. (2020) The burden of adult asthma in Finland: impact of disease severity and eosinophil count on health care resource utilization. Journal of Asthma 57:10, pages 1092-1102.
Read now
Read now
Georgios Hillas, Evangelia Fouka & Andriana I Papaioannou. (2020) Antibodies targeting the interleukin-5 signaling pathway used as add-on therapy for patients with severe eosinophilic asthma: a review of the mechanism of action, efficacy, and safety of the subcutaneously administered agents, mepolizumab and benralizumab. Expert Review of Respiratory Medicine 14:4, pages 353-365.
Read now
Read now
J Mark FitzGerald, Eugene R Bleecker, Arnaud Bourdin, William W Busse, Gary T Ferguson, Laura Brooks, Peter Barker & Ubaldo J Martin. (2019) Two-Year Integrated Efficacy And Safety Analysis Of Benralizumab In Severe Asthma. Journal of Asthma and Allergy 12, pages 401-413.
Read now
Read now
Gary T Ferguson, Jeremy Cole, Magnus Aurivillius, Paul Roussel, Peter Barker & Ubaldo J Martin. (2019) Single-Use Autoinjector Functionality And Reliability For At-Home Administration Of Benralizumab For Patients With Severe Asthma: GRECO Trial Results. Journal of Asthma and Allergy 12, pages 363-373.
Read now
Read now
Sean O’Quinn, Xiao Xu & Ian Hirsch. (2019) Daily patient-reported health status assessment improvements with benralizumab for patients with severe, uncontrolled eosinophilic asthma. Journal of Asthma and Allergy 12, pages 21-33.
Read now
Read now
Francis Nissen, Ian J Douglas, Hana Müllerová, Neil Pearce, Chloe I Bloom, Liam Smeeth & Jennifer K Quint. (2019) Clinical profile of predefined asthma phenotypes in a large cohort of UK primary care patients (Clinical Practice Research Datalink). Journal of Asthma and Allergy 12, pages 7-19.
Read now
Read now
Tadao Nagasaki, Keiko Sato, Naoto Kume, Tsuyoshi Oguma, Hironobu Sunadome, Isao Ito, Yumi Izuhara, Kazuya Okamoto, Shinji Kobayashi, Tomoya Ohno, Akiko Mizukami, Akihiro Kobayashi, Toshihiko Kaise, Tomohiro Kuroda, Michiaki Mishima & Hisako Matsumoto. (2019) The prevalence and disease burden of severe eosinophilic asthma in Japan. Journal of Asthma 56:11, pages 1147-1158.
Read now
Read now
Michel Aubier, Gabriel Thabut & Caroline Fabry-Vendrand. (2018) Characteristics of patients with severe, uncontrolled, eosinophilic asthma enrolled in a French cohort. Journal of Asthma and Allergy 11, pages 217-224.
Read now
Read now
Gary T Ferguson, Adel H Mansur, Joshua S Jacobs, Jacques Hebert, Corbin Clawson, Wenli Tao, Yanping Wu & Mitchell Goldman. (2018) Assessment of an accessorized pre-filled syringe for home-administered benralizumab in severe asthma. Journal of Asthma and Allergy 11, pages 63-72.
Read now
Read now
Garry M. Walsh. (2018) Recent developments in the use of biologics targeting IL-5, IL-4, or IL-13 in severe refractory asthma. Expert Review of Respiratory Medicine 12:11, pages 957-963.
Read now
Read now
Mika J. Mäkelä, Helene Nordahl Christensen, Antti Karlsson, Sarang Rastogi & Kirsi Kettunen. (2018) Health care resource utilization and characteristics of patients with eosinophilic asthma in secondary health care in Finland. European Clinical Respiratory Journal 5:1.
Read now
Read now
Gene Colice, David Price, Maria Gerhardsson de Verdier, Karma Rabon-Stith, Christopher Ambrose, Katherine Cappell, Debra E Irwin, Paul Juneau & Anna Vlahiotis. (2017) The effect of DPP-4 inhibitors on asthma control: an administrative database study to evaluate a potential pathophysiological relationship. Pragmatic and Observational Research 8, pages 231-240.
Read now
Read now
Jaco Voorham, Bernard Vrijens, Job FM van Boven, Dermot Ryan, Marc Miravitlles, Lisa M Law & David B Price. (2017) Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort study. Pragmatic and Observational Research 8, pages 31-41.
Read now
Read now
Mitchell Goldman, Ian Hirsch, James G. Zangrilli, Paul Newbold & Xiao Xu. (2017) The association between blood eosinophil count and benralizumab efficacy for patients with severe, uncontrolled asthma: subanalyses of the Phase III SIROCCO and CALIMA studies. Current Medical Research and Opinion 33:9, pages 1605-1613.
Read now
Read now
Dermot Ryan, John Blakey, Alison Chisholm, David Price, Mike Thomas, Björn Ställberg, Karin Lisspers & Janwillem W. H. Kocks. (2017) Use of electronic medical records and biomarkers to manage risk and resource efficiencies. European Clinical Respiratory Journal 4:1.
Read now
Read now
Andriana I. Papaioannou, Konstantinos Kostikas, Petros Bakakos, Anastasia Papaporfyriou, Elissavet Konstantellou, Georgios Hillas, Georgios Papatheodorou, Nikolaos G. Koulouris, Spyridon Papiris & Stelios Loukides. (2016) Predictors of future exacerbation risk in patients with asthma. Postgraduate Medicine 128:7, pages 687-692.
Read now
Read now
Articles from other publishers (17)
Qing Wang, Shihan Xu, Fenglan Liu, Yanfei Liu, Yue Liu & Fengqin Xu. (2023) Development of risk prediction model for cognitive impairment in patients with coronary heart disease: A study protocol for a prospective, cross-sectional analysis. Frontiers in Cardiovascular Medicine 9.
Crossref
Crossref
Yenealem Solomon, Berhanu Woldu, Nebiyu Mesfin & Bamlaku Enawgaw. (2022) Selected hematological abnormalities and their associated factors among asthmatic patients in Northwest Ethiopia: a cross-sectional study. BMC Pulmonary Medicine 22:1.
Crossref
Crossref
Holly Tibble, Aziz Sheikh & Athanasios Tsanas. (2022) Derivation of asthma severity from electronic prescription records using British thoracic society treatment steps. BMC Pulmonary Medicine 22:1.
Crossref
Crossref
A. Yu. Kraposhina, E. A. Sobko, I. V. Demko, A. B. Katser, O. V. Kazmerchuk, Yu. I. Abramov & S. V. Chubarova. (2022) New options for severe asthma. Meditsinskiy sovet = Medical Council 16:18, pages 20-28.
Crossref
Crossref
Konstantinos Porpodis, Ioanna Tsiouprou, Apostolos Apostolopoulos, Polyxeni Ntontsi, Evangelia Fouka, Despoina Papakosta, Harissios Vliagoftis & Kalliopi Domvri. (2022) Eosinophilic Asthma, Phenotypes-Endotypes and Current Biomarkers of Choice. Journal of Personalized Medicine 12:7, pages 1093.
Crossref
Crossref
L. Klimek, J. Hagemann, H. J. Welkoborsky, M. Cuevas, I. Casper, U. Förster-Rurmann, F. Klimek, C. A. Hintschich, T. Huppertz, K.-Ch. Bergmann, P. V. Tomazic, C. Bergmann & S. Becker. (2021) T2-Inflammation bei entzündlichen Atemwegserkrankungen: Grundlage neuer Behandlungsoptionen. Laryngo-Rhino-Otologie 101:02, pages 96-108.
Crossref
Crossref
Yiwen Li, Jing Cui, Yanfei Liu, Keji Chen, Luqi Huang & Yue Liu. (2021) Development and Validation of Risk Prediction Model for New-Onset Diabetes After Percutaneous Coronary Intervention (NODAP): A Study Protocol for a Retrospective, Multicenter Analysis. Frontiers in Cardiovascular Medicine 8.
Crossref
Crossref
Emanuela di Palmo, Erika Cantarelli, Arianna Catelli, Giampaolo Ricci, Marcella Gallucci, Angela Miniaci & Andrea Pession. (2021) The Predictive Role of Biomarkers and Genetics in Childhood Asthma Exacerbations. International Journal of Molecular Sciences 22:9, pages 4651.
Crossref
Crossref
Chiao-Juno Chiu & Miao-Tzu Huang. (2021) Asthma in the Precision Medicine Era: Biologics and Probiotics. International Journal of Molecular Sciences 22:9, pages 4528.
Crossref
Crossref
Jonathan Stewart, Frank Kee & Nigel Hart. (2021) Using routinely collected primary care records to identify and investigate severe asthma: a scoping review. npj Primary Care Respiratory Medicine 31:1.
Crossref
Crossref
Jung-Eun Kim, Dong-Hyun Lee, Keunok Jung, Eun-Ji Kim, Youngwoo Choi, Hae-Sim Park & Yong-Sung Kim. (2021) Engineering of Humanized Antibodies Against Human Interleukin 5 Receptor Alpha Subunit That Cause Potent Antibody-Dependent Cell-Mediated Cytotoxicity. Frontiers in Immunology 11.
Crossref
Crossref
Min Feng, Xin Zhang, Wen Wen Wu, Zhi Hong Chen, Brian G. Oliver, Vanessa M. McDonald, Hong Ping Zhang, Min Xie, Ling Qin, Jie Zhang, Lei Wang, Wei Min Li, Gang Wang & Peter G. Gibson. (2020) Clinical and Inflammatory Features of Exacerbation-Prone Asthma: A Cross-Sectional Study Using Multidimensional Assessment. Respiration 99:12, pages 1109-1121.
Crossref
Crossref
Natal'ya M. Nenasheva. (2019) Т2-high and T2-low bronchial asthma, endotype characteristics and biomarkers. Russian Pulmonology 29:2, pages 216-228.
Crossref
Crossref
Holly Tibble, Athanasios Tsanas, Elsie Horne, Robert Horne, Mehrdad Mizani, Colin R Simpson & Aziz Sheikh. (2019) Predicting asthma attacks in primary care: protocol for developing a machine learning-based prediction model. BMJ Open 9:7, pages e028375.
Crossref
Crossref
Alan Kaplan, Antony Hardjojo, Shaylynn Yu & David Price. (2019) Asthma Across Age: Insights From Primary Care. Frontiers in Pediatrics 7.
Crossref
Crossref
Paolo Solidoro, Michela Bellocchia, Ilaria Aredano, Alessio Mattei, Emanuele Pivetta, Filippo Patrucco, Monica Boita, Francesca de Blasio, Luisa Brussino, Giovanni Rolla & Caterina Bucca. (2017) Asthmatic Patients with Vitamin D Deficiency have Decreased Exacerbations after Vitamin Replacement. Nutrients 9:11, pages 1234.
Crossref
Crossref
Gilda Varricchi, Gianenrico Senna, Stefania Loffredo, Diego Bagnasco, Matteo Ferrando & Giorgio Walter Canonica. (2017) Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine?. Frontiers in Immunology 8.
Crossref
Crossref